PTC Therapeutics
PTCT
#2993
Rank
NZ$9.70 B
Marketcap
NZ$116.13
Share price
-0.20%
Change (1 day)
-9.85%
Change (1 year)

EPS for PTC Therapeutics (PTCT)

EPS in 2023 (TTM): NZ-$13.98

According to PTC Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.87. In 2022 the company made an earnings per share (EPS) of NZ-$13.85 a decrease over its 2021 EPS that were of NZ-$13.21.

EPS history for PTC Therapeutics from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$13.980.9%
2022NZ-$13.854.85%
2021NZ-$13.2111.39%
2020NZ-$11.8649.22%
2019NZ-$7.9566.17%
2018NZ-$4.7829.33%
2017NZ-$3.70-50.12%
2016NZ-$7.41-17.59%
2015NZ-$9.0057.63%
2014NZ-$5.7114.57%
2013NZ-$4.98201.61%
2012NZ-$1.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.34-1,171.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$30.81-3,636.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$3.86 342.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ-$4.68 436.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ-$1.87 114.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ-$7.43 753.06%๐Ÿ‡บ๐Ÿ‡ธ USA